Search
Search
Cafe Scientifique
Approximately nine per cent of Canadian adults will experience post-traumatic stress disorder (PTSD) at some point in their lifetime (Canadian Mental Health Association). As trauma and trauma-related disorders have become more recognized in society, the need for research has accelerated. At London Health Sciences Centre and St. Joseph’s Health Care London, our researchers are leading the way in advancing understanding, diagnosis and treatment in this critical area of mental health.
Join Lawson Health Research Institute on Thursday, September 28th at Goodwill Industries for a special Café Scientifique event, “Uncovering Trauma: A Conversation about PTSD and Moral Injury.”
Our world-renowned researchers and those with lived experience will share the importance of addressing trauma, PTSD and moral injury. They will discuss diagnosis, prognosis and treatment advancements developed through studies involving at-risk populations, including Canadian Veterans, health-care workers and those with developmental trauma.
EVENT DETAILS
- Date: Thursday, September 28, 2023
- Time: 6:30-9:00 p.m. (Doors open at 6:00 pm)
- Location: Goodwill Industries
- 255 Horton Street, London, ON (3rd floor event space)
https://goo.gl/maps/J65qJy6HKtg4aDxEA - Parking: Free on-site parking
PANELISTS
- Dr. J. Don Richardson, Associate Scientist at Lawson, Consultant Psychiatrist and Medical Director of the Parkwood Operational Stress Injury (OSI) Clinic at St. Joseph’s Health Care London, Scientific Director of the MacDonald Franklin OSI Research Centre at the Parkwood Institute, Fellow with the Canadian Institute for Military and Veteran Health, Tanna Schulich Chair in Neuroscience & Mental Health and Professor of Psychiatry at Western University
- Dr. Ruth Lanius, Associate Scientist at Lawson, Psychiatrist at London Health Sciences Centre, Harris-Woodman Chair in Mind-Body Medicine and Professor of Psychiatry at Western University’s Schulich School of Medicine & Dentistry
- Teresa Kinney, research participant who has contributed to studies with Dr. Lanius
- Laryssa Lamrock, National Strategic Advisor for families at Atlas Institute for Veterans and Families, Veterans Family Advisor on the MacDonald Franklin OSI Research Centre Advisory Council
MODERATOR
- Dr. Arlene MacDougall, Scientist at Lawson, Director of Research and Innovation for Mental Health at St. Joseph’s Health Care London, Director for MINDS, the Mental Health Incubator for Disruptive Solutions of London-Middlesex, Assistant Professor of Psychiatry and Epidemiology & Biostatistics at Western University
This is a free event and online registration is REQUIRED. Click here to register.
Café Scientifique is a free community event providing an informal opportunity to get involved with science. Through an open-forum discussion in a casual setting, these events address health-related issues of popular interest to the general public. A panel of Lawson researchers talk about what they do and why, and share their unique research perspectives. Guests can then ask questions, participate in discussion, and gain insights from the speakers and from one another.
This event is made possible by funding from the Canadian Institutes of Health Research (CIHR).
Thanks to our media partner:

Canadian National Perinatal Research Meeting
Canadian National Perinatal Research Meeting
Dates: Tuesday, February 14 - Friday, February 17, 2017
Location: Montebello, Quebec
Program: To view the full event program, please visit the Canadian National Perinatal Research Meeting website.
Event Information
The primary objectives of the meeting are to foster collaborative research in Canada and help train research leaders for tomorrow. Practitioners, research investigators and trainees learn about the latest discoveries in maternal, fetal and newborn health research for application to maternal and newborn care and policy.
This year’s program promises to be a unique mix of interdisciplinary collaboration as well as an opportunity for discipline-specific sub-groups to share the latest developments in their own fields. The conference boasts outstanding national and international guest speakers and provides considerable time for oral and poster presentation of original work from attending participants.
This year's event is being co-chaired by Lawson's Timothy Regnault.
For more information and to register, please visit the Canadian National Perinatal Research Meeting website.
10 reasons to attend the Canadian National Perinatal Research Meeting
1. Room and board are provided at subsidized rates to all trainees whether or not presenting a paper.
2. Physicians will earn Continuing Medical Education credits.
3. The scenery at the Fairmont Le Chateau Montebello is stunning.
4. The reviewers of your Canadian grant applications will likely be attending; it's the perfect opportunity to promote your work.
5. The food and rooms are first-class.
6. World-class, leading international speakers will be presenting.
7. Thematic sessions highlight the latest advances in specialized areas of perinatal health.
8. Learn about the future of perinatal research in Canada from the Director of the CIHR Institute of Human Development, Child and Youth Health.
9. Excellent opportunity to meet your colleagues from across Canada, to discuss current ideas in perinatal health and to set up new collaborations.
10. This is YOUR Canadian National Perinatal Research Meeting and it needs your support.
Celebrating Clinical Trials Day
Clinical trials are the gold standard in medical research, used to test new treatments and medical devices to ensure they are safe and improve patient outcomes.
Each year on May 20, Clinical Trials Day aims to raise awareness about the importance of clinical trials. At Lawson Health Research Institute, our researchers, research staff and learners across London Health Sciences Centre (LHSC) and St. Joseph’s Health Care London (St. Joseph’s) are working daily to advance clinical trials for some of the most pressing health challenges.
“If you look at many areas of medicine, like cancer and cardiovascular disease, part of why those conditions have had dramatic improvements in outcomes over the last several decades is because of clinical trials,” says Dr. Amit Garg, Scientist at Lawson, Lead for the Kidney, Dialysis & Transplantation Research Program at ICES Western, and a Nephrologist at LHSC.
Clinical trials can also provide patient participants with new treatment options and can demonstrate when existing treatments have applications for other diseases.
“We could not conduct clinical trials without patients participating in them,” adds Dr. David Palma, Associate Scientist at Lawson and Radiation Oncologist at LHSC. “A clinical trial is a very rigorous process where we carefully define a treatment and follow patients very closely with extra interventions and tests to see not only how the disease is responding to treatment, but also any effects on a patient’s quality of life.”
It also takes a team to make clinical trials a success, including the critical work of research coordinators, associates and assistants, adds Dr. Swati Mehta, Lawson Scientist based at St. Joseph’s Parkwood Institute.
Dr. Palma also notes that while clinical trials require investment to conduct them, they can ultimately lead to savings in the health system.
“While the primary goal of a clinical trial is to improve or save lives, they often lead to cost savings down the road. Improving cure rates means people don’t need as much treatment and that can save the initial investment many, many times over,” Palma says.
Looking ahead, work is ongoing to make clinical trials more efficient and equitable.
“Eliminating specialized infrastructure would help make trials more equitable, so they are available in smaller communities and at distant sites that otherwise would not have access. Making study materials available in multiple languages and to anyone with accessibility issues can also help,” Garg adds.
“Future clinical trials will need to follow more pragmatic, adaptive study designs that allow us to evaluate therapies or interventions in a more realistic setting,” Dr. Mehta says. “These would also allow us to follow-up with patients that were potentially underrepresented in past research.”
According to researchers at Lawson, the future of clinical trials is bright with hundreds of trials currently underway at LHSC and St. Joseph’s with the goal of improving patient outcomes.
Celebrating International Women’s Day
To mark International Women’s Day, two early career researchers at Lawson Health Research Institute are sharing their experiences as women in STEM (science, technology, engineering and math). They shared the support they’ve experienced in their careers, the importance of women’s voices in medical research and how to encourage more women to pursue careers in STEM.
Early access and mentorship are key: Dr. Funmbi Babalola
Dr. Babalola is a Paediatric Endocrinologist at Children’s Hospital at London Health Sciences Centre (LHSC) and an Associate Scientist at Lawson Health Research Institute. She helped pioneer the start of a Paediatric Rare Bone Disease Clinic at Children’s Hospital in 2022 which provides multi-disciplinary care for patients, so they no longer have to travel outside of London for treatment. As a clinician researcher, her areas of interest are paediatric diabetes and calcium and bone metabolism disorders. She is currently involved in several clinical trials and studies.
She credits mentorship and the support of educators early in her career journey with encouraging her interest in science and says that is key for being more welcoming to women in STEM.
“In Grade 12 my biology teacher recommended I go to an advanced placement school. That was when I had my first experience with research,” says Dr. Babalola. “When I got to my undergraduate work, I found a woman mentor who was a powerhouse and had a vision, and I was able to publish two papers during that time and had such a positive experience. I went straight to medical school after that and continued to do research. I think I’ve been really lucky with all the people that I’ve worked with and who have encouraged me as I built my research career.”
Dr. Babalola says she is fortunate to be a researcher in a time when women’s voices are finally being heard and welcomed.
“I think my perspective is probably different than women who were starting work 10 or 20 years ago,” she notes. “I think I’m very lucky that I entered the medical research world where a lot of women are at the table. They’re great role models and they really support and help each other.”
But she says support for research in hospitals is also crucial.
“It takes both good mentors and a culture of research to make it easier to get studies done.”
Dr. Babalola has already started mentoring new researchers, many of them women, who have approached her.
“I’m all about paying it forward. I’ve been super fortunate to have great mentors that are still continuing to mentor me, so I want to pass that knowledge on.”
Women in science are inspirational: Dr. Kait Al
Dr. Kait Al is a Postdoctoral Research Fellow at Western University’s Schulich School of Medicine & Dentistry, working in a Lawson Health Research Institute lab at St. Joseph’s Health Care London. Dr. Al’s research focus is the role of the microbiome in urological conditions like kidney stone disease. She’s currently looking at how a microbiome with beneficial microbes could help protect healthy individuals from forming kidney stones and how optimizing the microbiome could help prevent stone recurrence in stone formers.
She believes women’s voices need to be included in research so that it is more representative of the world we live in and better addresses everyone’s health needs.
“Women bring diverse experiences and perspectives that have been historically excluded from research, along with many other underrepresented groups.”
And mentors among those voices are one of the best ways to encourage more women to get interested in science, she says, so women can see themselves in those positions.
“Seeing someone like yourself as a role model in a successful position that is passionate and curious about science can be so influential to young people,” shares Dr. Al. “As scientists, it’s important to share your work widely.”
She notes that organizations that encourage and support mentorship, as well as a flexible work culture and networking opportunities, are likely to be more welcoming to women in STEM and benefit from having them as part of the team.
“It is crucial to prioritize an inclusive and supportive mentorship environment for trainees and professionals,” says Dr. Al. “I believe work that lets you balance professional and personal commitments, which can otherwise be biased against women, is key.”
The theme for International Women’s Day in 2024 is ‘Inspire Inclusion,’ and that’s exactly what Dr. Al says she sees in other women in science.
“I am constantly inspired by women in science, from my direct colleagues to world leaders I’ve never met. I have witnessed firsthand my colleagues breaking down barriers, succeeding in challenging areas, and lifting each other up, and it really creates a culture of empowerment.”
Celebrating the 2022 Lawson Impact Award winners
The Lawson Impact Awards are a pinnacle of celebration in the Lawson Health Research Institute community, celebrating innovation across London Health Sciences Centre (LHSC) and St. Joseph’s Health Care London. The Impact Awards recognize hospital-based research that makes a difference by advancing scientific knowledge and applying it directly to patient care.
With awards in eight categories, the annual awards honour Lawson scientists, staff, trainees and partners who demonstrate excellence.
“The Lawson Impact Awards are a celebration of the research mission of LHSC and St. Joseph’s,” says Dr. David Hill, Scientific Director at Lawson. “There is innovation happening every day here in London, Ontario. The environment and close proximity to patient care allow us to hire great scientists that flourish in our research space.”
Recognized for his high-impact work over the past several years, Dr. Douglas Fraser was named as Lawson’s Scientist of the Year – the Lawson Impact Awards’ highest honour. Dr. Fraser, who is a Scientist at Lawson and Critical Care Physician at Children’s Hospital at London Health Sciences Centre (LHSC), has led the way in a number of areas of research. Over the past few years, he has published numerous studies and signed multiple licensing agreements that show promise for improving the diagnosis and treatment of concussion, COVID-19 and long COVID.
“Research is exciting to me and I love showing up to work. We have great colleagues, wonderful resources which allows us to ask good questions and it is a pleasure coming to work each day,” says Dr. Fraser, who is also a Professor at Western University’s Schulich School of Medicine & Dentistry. “It I always an honor to be recognized and humbling as well, because most of the work we have done has always been a group effort.”
Dr. Fraser is one of eight 2022 Lawson Impact Award recipients.
A big congratulations to all of this year’s winners, as well as our 2022 Lawson Strategic Research Fund recipients:
Scientist of The Year Award: Dr. Douglas Fraser
Dr. Joseph Gilbert Research Contribution of The Year Award: Dr. Daniel Hardy
Innovation Award: Dr. Dalton Wolfe
London Health Sciences Foundation Community Partner Of The Year Award: Archie Verspeeten
St. Joseph's Health Care Foundation Community Partner Of The Year Award: Dr. Joseph Rea
Children's Health Foundation Community Partner Of The Year Award: Dr. Paul and Mrs. Mary Harding
Leadership Award for Fellows & Students: Karnig Kazazian
Staff Award Of Excellence: Dr. Jeff Weiler
Strategic Research Fund Recipients: Dr. Matthew Teeter & Dr. Jonathan Thiessen and Dr. Luciano Sposato & Dr. Frank Prato
You can visit the full Impact Awards site by clicking here
Senior Media Relations Consultant
Communications & Public Engagement
T: 519-685-8500 ext. 73502
Celine.zadorsky@lhsc.on.ca
Children born in Sarnia at higher risk of developing asthma, compared to London and Windsor
LONDON, ON – New findings from Ontario have shown that children born in Sarnia have a higher risk of developing asthma compared to neighbouring cities. A research team from Lawson Health Research Institute and Western University, using provincial data from ICES, found that higher air pollution exposure in the first year of life very likely contributed to this higher risk. Their results are published today in CMAJ Open.
Summary of study results:
- Children born in Sarnia in the 1990s and early 2000s were disproportionally at a higher risk of developing asthma in the first few years of life, compared to neighbouring cities.
- Air pollution exposure in the first year was found to be associated with the development of asthma in children.
- Overall rates of new childhood asthma diagnosis in Southwestern Ontario have been decreasing over time in parallel to decreases in air pollution levels.
“It’s known that cities in Southwestern Ontario have varied levels of air pollution because of differences in industry and traffic. For example, Sarnia is home to the ‘Chemical Valley’ where numerous chemical plants and oil refineries are clustered,” says Dr. Dhenuka Radhakrishnan, an Adjunct ICES Scientist, formerly working out of ICES Western in London, and Pediatric Respirologist at CHEO. “We wanted to see if children born in three cities – London, Windsor and Sarnia – had a different risk of developing asthma due to the differing air pollution levels in the three regions, even though the people living in these cities are otherwise comparable in many ways.”
The researchers followed 114,427 children born in these cities between 1993 and 2009 for 10 years, and found that those in Sarnia were at the highest risk of developing asthma. The researchers found that by the age of 10, nearly 24 per cent of children in Sarnia were diagnosed with asthma, compared to 21 per cent in Windsor and 17 per cent in London. The differences were also present after accounting for many risk factors associated with asthma, such as sex, socioeconomic status and urban versus rural setting. The findings were most apparent in the first two years of life, but persistent beyond the age of six.
“Reassuringly, we found the asthma risk for children has reduced in more recent years as pollution levels have also decreased,” adds Dr. Radhakrishnan.
Asthma is the most common chronic disease in Canadian children and has significant impact on quality of life. Asthma is the leading cause of emergency department visits and hospital admissions in this age group.
“It’s important to find strategies to prevent asthma development and this study suggests that reducing air pollution exposure, including environmental causes, might reduce the number of children who suffer from asthma,” explains Dr. Salimah Shariff, Associate Scientist at Lawson, Adjunct Professor at Western and Scientist at ICES Western.
There is also growing evidence that exposure during pregnancy can influence development of asthma in children. “We need to carefully examine how reducing air pollution exposures within a geographic area translates to reductions in asthma development. Understanding the amount of air pollution that a mother and infant are exposed to, and how this impacts their personal risk, could enable regions to target safer levels for their residents,” adds Dr. Shariff.
Wednesday, May 5 is World Asthma Day (WAD). Recognizing symptoms of asthma early is the best a parent can do to improve the health of their child, so they can be diagnosed quickly and start appropriate treatments. If a parent notices their child has wheezing, persistent cough or difficulty with exercise, they are encouraged to bring this to the attention of a health care provider.
-30-
DOWNLOADABLE MEDIA
Child using an age-appropriate valved spacer device with an asthma inhaler. They should be used together for children to ensure the medication is properly delivered to the lungs.
Child using an age-appropriate valved spacer device with an asthma inhaler. They should be used together for children to ensure the medication is properly delivered to the lungs.
Dr. Dhenuka Radhakrishnan, an Adjunct ICES Scientist, formerly working out of ICES Western in London, and Pediatric Respirologist at CHEO
Dr. Salimah Shariff, Associate Scientist at Lawson, Adjunct Professor at Western and Scientist at ICES Western
Proportion of children with an asthma diagnosis by studied region
Lawson Health Research Institute is one of Canada’s top hospital-based research institutes, tackling the most pressing challenges in health care. As the research institute of London Health Sciences Centre and St. Joseph’s Health Care London, our innovation happens where care is delivered. Lawson research teams are at the leading-edge of science with the goal of improving health and the delivery of care for patients. Working in partnership with Western University, our researchers are encouraged to pursue their curiosity, collaborate often and share their discoveries widely. Research conducted through Lawson makes a difference in the lives of patients, families and communities around the world. To learn more, visit www.lawsonresearch.ca.
Western delivers an academic experience second to none. Since 1878, The Western Experience has combined academic excellence with life-long opportunities for intellectual, social and cultural growth in order to better serve our communities. Our research excellence expands knowledge and drives discovery with real-world application. Western attracts individuals with a broad worldview, seeking to study, influence and lead in the international community.
The Institute for Clinical Evaluative Sciences (ICES) is an independent, non-profit organization that uses population-based health information to produce knowledge on a broad range of health care issues. Our unbiased evidence provides measures of health system performance, a clearer understanding of the shifting health care needs of Ontarians, and a stimulus for discussion of practical solutions to optimize scarce resources. ICES knowledge is highly regarded in Canada and abroad, and is widely used by government, hospitals, planners, and practitioners to make decisions about care delivery and to develop policy. For the latest ICES news, follow us on Twitter: @ICESOntario
Senior Media Relations Consultant
Communications & Public Engagement
T: 519-685-8500 ext. 73502
Celine.zadorsky@lhsc.on.ca
Clinical Research
Research at Lawson spans the continuum of life and mirrors the clinical areas of across St. Joseph’s Health Care London. Lawson is involved in all types and phases of clinical trials. Ethical clinical research and participant safety are our utmost priority.
Where does clinical research happen?
Depending on the research being done, it can take place in many different locations, including:
- Doctor’s offices
- Hospitals
- Medical centres
- Community nusing stations
- Academic centres, such as universities and medical schools
- Clinics
- At your home
Frequently Asked Questions
- What is a clinical trial?
- Participating in clinical trials
- Regulations and guidelines
- Considerations for participants and questions to ask
- Clinical Trials Ontario
- It Starts With Me
- Where can I find open clinical trials?
Contact
If you have questions, please call 519-667-6649 or email @email.